Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489861 - 489880 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AF07) deucravacitinib (adm: O) | SOTYKTU 6MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | Bristol-MyersSquibbCompany |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG AUTO INJECTOR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG AUTO INJECTOR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG PREFILLED SYR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA 200MG PREFILLED SYR | 4X1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (120MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (120MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (400MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG04) belimumab (adm: P) | BENLYSTA LYOPHILIZED (400MG/VL) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS 300MG/10ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | GenentechUSA,Inc. |
| USA | (L04AG14) ublituximab | BRIUMVI 25MG/ML INJ,SOLN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | TGTherapeutics,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | FYARRO 100MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AadiBioscience,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 1MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 1MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 2MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AH01) sirolimus (adm: O) | RAPAMUNE 2MG TAB | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | Pfizer,Inc. |
| USA | (L04AJ01) eculizumab (adm: P) | SOLIRIS 10MG/ML 30ML VIAL | 1X30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
| USA | (L04AJ01) eculizumab (adm: P) | SOLIRIS 10MG/ML 30ML VIAL | 1X30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
| USA | (L04AJ02) ravulizumab (adm: P) | ULTOMIRIS 100MG/ML INJ,SOLN | 11ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsInc. |
Pages
